Position in RGNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$282,787
+$196,901 QoQ
Shares Held
23,605
+130.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#90
of 164 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INCEPTIONR LLC holds $18,792,382 across 35 Biotechnology names. RGNX ranks #25 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
24,251 | $1,922,861 | |
| 2 | CYTK |
Cytokinetics Inc
|
17,151 | $1,461,093 | |
| 3 | INSM |
INSMED Inc
|
12,296 | $1,310,999 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
5,225 | $1,278,923 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
9,353 | $1,038,463 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
8,122 | $950,842 | |
| 7 | RPRX |
Royalty Pharma plc
|
16,614 | $931,546 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,262 | $786,907 |
All Filings in RGNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,787 | 23,605 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $85,886 | 10,249 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $251,136 | 17,440 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $117,286 | 12,154 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $119,323 | 11,375 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||